SLC6A1 and colorectal carcinoma: This study found that the SLC6A1 expression was significantly elevated in CRC, and the multifactorial analysis showed that the SLC6A1 expression was an independent prognostic marker of the overall survival in CRC patients, which was consistent with the previous findings.